Oct. 6 at 2:16 AM
$TRIB Big Upgrade
-In its established HbA1c testing business, Trinity Biotech has also introduced a new column and buffer combination that delivers up to four times the number of injections compared to the existing product. This innovation offers greater stability, requires less calibration, and reduces the cost of goods, enhancing the company's competitiveness and enabling it to target segments of the A1C testing market previously inaccessible due to pricing pressures.
